The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein

Published:2013-03 Issue:2 Volume:41 Page:77-83
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Lee Jung-Hwan,Cho Jong Ho,Yeo Jiwoo,Lee Sung Hee,Yang Se Hwan,Sung Young Chul,Kang Ju-Hee,Park Chang-Shin

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference35 articles.

1. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review;Tracey;Pharmacol Ther,2008

2. Functional comparisons of different tumor necrosis factor receptor/IgG fusion protein;Scallon;Cytokine,1995

3. Infections and biological therapy in rheumatoid arthritis;Cunnane;Best Pract Res Clin Rheumatol,2003

4. Clinical pharmacokinetics of TNF antagonist: how do they differ?;Nestorov;Semin Arthritis Rheum,2004

5. Etanercept: an overview;Goffe;J Am Acad Dermatol,2003

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autocrine positive feedback of tumor necrosis factor from activated microglia proposed to be of widespread relevance in chronic neurological disease;Pharmacology Research & Perspectives;2023-09-26

2. Coronavirus (SARS-CoV-2): a systematic review for potential vaccines;Human Vaccines & Immunotherapeutics;2021-02-05

3. Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development;Asian Journal of Pharmaceutical Sciences;2021-01

4. A glycosylated Fc ‐fused glucagon‐like peptide‐1 receptor agonist exhibits equivalent glucose lowering to but fewer gastrointestinal side effects than dulaglutide;Diabetes, Obesity and Metabolism;2020-06-03

5. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19);Journal of Microbiology and Biotechnology;2020-03-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3